This morning we were treated to good news from Omega Diagnostics* (ODX), who confirmed that they have resolved the manufacturing variability issues with Visitect CD4, their point-of-care test for assessing the levels of CD4 in the blood (which indicates when to start treatment for HIV). The firm said it has now made three pilot batches…
The nonsense peddled by much of the left-wing press (not to mention some in the Conservative Party who ought to know better) regarding poverty has long been a bugbear of mine. Accustomed to unprecedented levels of wealth and prosperity, our concept of poverty has become so warped of late that we regard people unable to…
I have often sung the praises of set-top box manufacturer (and Cambridge silicon fen resident) Amino Technologies (AMO), and the recent takeover of Pace (PIC) by US telecoms firm Arris prompts me to revisit the investment case. Obviously, this is a sector where great change is prompting big players to look to M&A action in…
Shareholders in Vectura* (VEC), of which I am one, should breathe easy following this morning’s results from the inhaled medicines specialist. Vectura has reported a maiden profit after tax of £3.7 million on the back of revenues up by 59% to £58 million. However, this is just the beginning, as Vectura is now a company…
Featured in this month’s Master Investor Magazine. Often, a company can have an exciting product in the pipeline for years and remain relatively unnoticed until some kind of catalyst grabs the attention of the market and sends the share price rocketing. No-one has a crystal ball, but more often than not in these cases, such…
I last looked at Advanced Oncotherapy (AVO) back in the Spreadbet Magazine days, having identified them as part of a crop of “speculative small caps that could be set to surprise on the upside in 2015”. Well, certainly haven’t disappointed in that regard, having soared from around 4p at the time of my original article…
When Disney met Star Wars Being a huge Star Wars fan, I confess to having felt a pang of child-like excitement upon hearing that Disney had released a new trailer for the first instalment of the third trilogy in the franchise. Although it certainly piqued my interest, I had been somewhat underwhelmed by the first…
“The US government has a technology, called a printing press (or, today, its electronic equivalent), that allows it to produce as many US dollars as it wishes at essentially no cost.” Such was the observation of Ben Bernanke during his time as an academic before he became chairman of the Federal Reserve. Although Bernanke was…
Sell-offs are often a great opportunity for patient investors to acquire prime assets on the cheap, and the recent sell-off in the oil & gas services sector appears to be a case in point. In this month’s small-cap section we have put together a selection of the most exciting companies in the sector, all of…
In a booming market, many of the best opportunities are to be found using a picks ‘n’ shovels investment approach – in other words, via investing in those companies that facilitate rather than produce. To a large extent, the same was true of the last bull market in the oil & gas sector. While the…
